ES8703876A1 - Un procedimiento para la preparacion de derivados de purina. - Google Patents

Un procedimiento para la preparacion de derivados de purina.

Info

Publication number
ES8703876A1
ES8703876A1 ES547128A ES547128A ES8703876A1 ES 8703876 A1 ES8703876 A1 ES 8703876A1 ES 547128 A ES547128 A ES 547128A ES 547128 A ES547128 A ES 547128A ES 8703876 A1 ES8703876 A1 ES 8703876A1
Authority
ES
Spain
Prior art keywords
purine derivatives
pharmaceutical use
compound
formula
reducing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES547128A
Other languages
English (en)
Spanish (es)
Other versions
ES547128A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848423833A external-priority patent/GB8423833D0/en
Priority claimed from GB858510331A external-priority patent/GB8510331D0/en
Priority claimed from GB858520618A external-priority patent/GB8520618D0/en
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of ES547128A0 publication Critical patent/ES547128A0/es
Publication of ES8703876A1 publication Critical patent/ES8703876A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/007—Esters of unsaturated alcohols having the esterified hydroxy group bound to an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES547128A 1984-09-20 1985-09-19 Un procedimiento para la preparacion de derivados de purina. Expired ES8703876A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB848423833A GB8423833D0 (en) 1984-09-20 1984-09-20 Compounds
GB858510331A GB8510331D0 (en) 1985-04-23 1985-04-23 Compounds
GB858520618A GB8520618D0 (en) 1985-08-16 1985-08-16 Compounds

Publications (2)

Publication Number Publication Date
ES547128A0 ES547128A0 (es) 1987-03-01
ES8703876A1 true ES8703876A1 (es) 1987-03-01

Family

ID=27262464

Family Applications (1)

Application Number Title Priority Date Filing Date
ES547128A Expired ES8703876A1 (es) 1984-09-20 1985-09-19 Un procedimiento para la preparacion de derivados de purina.

Country Status (24)

Country Link
EP (1) EP0182024B1 (OSRAM)
JP (2) JPS6185388A (OSRAM)
KR (1) KR930006349B1 (OSRAM)
AT (1) AT389118B (OSRAM)
AU (1) AU589371B2 (OSRAM)
BG (1) BG61493B2 (OSRAM)
CA (1) CA1262899A (OSRAM)
CY (1) CY1747A (OSRAM)
CZ (1) CZ283721B6 (OSRAM)
DE (1) DE3582399D1 (OSRAM)
DK (1) DK167019B1 (OSRAM)
ES (1) ES8703876A1 (OSRAM)
FI (1) FI87564C (OSRAM)
GR (1) GR852272B (OSRAM)
HK (1) HK128693A (OSRAM)
HU (1) HU198934B (OSRAM)
IE (1) IE58141B1 (OSRAM)
MX (1) MX165116B (OSRAM)
MY (1) MY102473A (OSRAM)
NL (1) NL960006I2 (OSRAM)
NO (1) NO167572C (OSRAM)
NZ (1) NZ213528A (OSRAM)
PT (1) PT81160B (OSRAM)
WO (1) WO1987005604A1 (OSRAM)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8406538D0 (sv) 1984-12-21 1984-12-21 Astra Laekemedel Ab Novel derivatives of purine
GB8628826D0 (en) * 1986-12-02 1987-01-07 Beecham Group Plc Pharmaceutical products
US5175288A (en) * 1987-08-01 1992-12-29 Beecham Group P.L.C. Process for preparing purine derivatives and intermediates thereof
EP0302644B1 (en) * 1987-08-01 1997-01-29 Beecham Group Plc Purine compounds and their preparation
GB8817270D0 (en) * 1988-07-20 1988-08-24 Beecham Group Plc Novel process
GB8817607D0 (en) * 1988-07-23 1988-09-01 Beecham Group Plc Novel process
GB8822236D0 (en) * 1988-09-21 1988-10-26 Beecham Group Plc Chemical process
CA2009109A1 (en) * 1989-02-02 1990-08-02 John Hannah Antiviral acyclonucleosides and acyclonucleotides
JPH02247191A (ja) * 1989-02-02 1990-10-02 Merck & Co Inc 抗レトロウイルス剤としてのプリンおよびピリミジン非環状ヌクレオシドの環状モノホスフエート類
GB8904855D0 (en) * 1989-03-03 1989-04-12 Beecham Group Plc Pharmaceutical treatment
GB8922076D0 (en) * 1989-09-28 1989-11-15 Beecham Group Plc Novel process
GB9004647D0 (en) * 1990-03-01 1990-04-25 Beecham Group Plc Pharmaceuticals
GB9102127D0 (en) * 1991-01-31 1991-03-13 Smithkline Beecham Plc Pharmaceuticals
GB9201961D0 (en) 1992-01-30 1992-03-18 Smithkline Beecham Plc Pharmaceuticals
IL111138A (en) * 1993-10-05 1997-04-15 Smithkline Beecham Plc Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
US6124304A (en) * 1993-10-05 2000-09-26 Smithkline Beecham Plc Penciclovir for the treatment of zoster associated pain
GB9326177D0 (en) * 1993-12-22 1994-02-23 Smithkline Beecham Plc Pharmaceuticals
US6683084B1 (en) 1993-11-12 2004-01-27 Novartis International Pharmaceutical Ltd. Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections
GB9323404D0 (en) * 1993-11-12 1994-01-05 Smithkline Beecham Plc Pharmaceuticals
GB9323403D0 (en) * 1993-11-12 1994-01-05 Smithkline Beecham Plc Pharmaceuticals
GB9402161D0 (en) 1994-02-04 1994-03-30 Wellcome Found Chloropyrimidine intermediates
GB9407698D0 (en) 1994-04-19 1994-06-15 Smithkline Beecham Plc Pharmaceuticals
DE4420751A1 (de) * 1994-06-15 1995-12-21 Basf Ag Verfahren zur Herstellung von enantiomerenreinen Lactamen
CN1045088C (zh) * 1994-10-05 1999-09-15 奇罗斯恩有限公司 用作pnp抑制剂的嘌呤和鸟嘌呤化合物
RU2181049C2 (ru) * 1994-12-12 2002-04-10 Новартис Интернэшнл Фармасьютикал Лтд. Использование аминопуриновых противовирусных соединений для лечения и профилактики латентных инфекций, вызванных вирусом герпеса
GB9504497D0 (en) * 1995-03-07 1995-04-26 Smithkline Beecham Plc Pharmaceuticals
GB9600847D0 (en) * 1996-01-16 1996-03-20 Smithkline Beecham Plc Pharmaceuticals
US7279483B2 (en) 1996-02-07 2007-10-09 Novartis Ag Famciclovir monohydrate
WO1997029108A1 (en) * 1996-02-07 1997-08-14 Smithkline Beecham Plc Famciclovir monohydrate
GB9615253D0 (en) * 1996-07-20 1996-09-04 Smithkline Beecham Plc Pharmaceuticals
ES2138535B1 (es) * 1996-07-20 2000-11-16 Smithkline Beecham Plc Procedimiento para la preparacion de los compuestos antivirales penciclovir y famciclovir.
GB9615276D0 (en) * 1996-07-20 1996-09-04 Smithkline Beecham Plc Pharmaceuticals
CA2251481A1 (en) 1997-11-12 1999-05-12 Junichi Yasuoka Purine derivatives having cyclopropane ring
GB9807116D0 (en) 1998-04-02 1998-06-03 Smithkline Beecham Plc Novel process
SI20022A (sl) * 1998-07-29 2000-02-29 Kemijski inštitut Alkilno substituirani purinovi derivati in njihova priprava
KR20040088519A (ko) 2002-02-22 2004-10-16 뉴 리버 파마슈티칼스, 인크. 활성 제제 전달 시스템 및 활성 제제의 보호 및 투여 방법
AU2003268213A1 (en) 2002-08-26 2004-03-11 Teva Pharmaceutical Industries Ltd. Crystalline solid famciclovir forms i, ii, iii and preparation thereof
WO2004064846A1 (en) 2003-01-14 2004-08-05 Gilead Sciences, Inc. Compositions and methods for combination antiviral therapy
AU2006230269A1 (en) 2005-03-30 2006-10-05 Novartis Ag Penciclovir or famciclovir for the treatment of recurrent genital herpes with a one-day application
GB2426247A (en) * 2005-05-20 2006-11-22 Arrow Int Ltd Methods of preparing purine derivatives such as famciclovir
TWI471145B (zh) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
TWI375560B (en) 2005-06-13 2012-11-01 Gilead Sciences Inc Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
WO2017029298A1 (en) 2015-08-17 2017-02-23 Sanovel Ilac Sanayi Ve Ticaret A.S. A topical antiviral composition
EP3386995A1 (en) * 2015-12-08 2018-10-17 Retrophin, Inc. Cyclic phosphates and cyclic phosphoramidates for the treatment of neurologic disorders
US20230218644A1 (en) 2020-04-16 2023-07-13 Som Innovation Biotech, S.A. Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5989682A (ja) * 1982-10-14 1984-05-23 ザ・ウエルカム・フアウンデ−シヨン プリン誘導体
EP0141927B1 (en) * 1983-08-18 1991-10-30 Beecham Group Plc Antiviral guanine derivatives
AU577303B2 (en) * 1983-08-18 1988-09-22 Novartis International Pharmaceutical Ltd 9-substituted-2-amino purines
DE3571810D1 (en) * 1984-01-26 1989-08-31 Merck & Co Inc Substituted butyl guanines and their utilization in antiviral compositions

Also Published As

Publication number Publication date
JPH0625241A (ja) 1994-02-01
AU4756085A (en) 1986-03-27
NO167572C (no) 1991-11-20
NZ213528A (en) 1989-03-29
NO167572B (no) 1991-08-12
DK424685D0 (da) 1985-09-18
HK128693A (en) 1993-11-26
JPS6185388A (ja) 1986-04-30
DE3582399D1 (de) 1991-05-08
NL960006I1 (nl) 1996-09-02
MY102473A (en) 1992-06-30
CS391591A3 (en) 1992-05-13
JPH0826021B2 (ja) 1996-03-13
KR930006349B1 (ko) 1993-07-14
EP0182024A3 (en) 1989-03-08
AU589371B2 (en) 1989-10-12
PT81160B (pt) 1988-01-22
NO874764L (no) 1987-11-16
FI87564C (fi) 1993-01-25
ES547128A0 (es) 1987-03-01
BG61493B2 (bg) 1997-09-30
NL960006I2 (nl) 1996-09-02
IE852307L (en) 1986-03-20
DK167019B1 (da) 1993-08-16
JPH0586792B2 (OSRAM) 1993-12-14
GR852272B (OSRAM) 1986-01-21
AT389118B (de) 1989-10-25
PT81160A (en) 1985-10-01
CA1262899A (en) 1989-11-14
EP0182024B1 (en) 1991-04-03
FI875059A0 (fi) 1987-11-16
ATA904286A (de) 1989-03-15
WO1987005604A1 (en) 1987-09-24
CY1747A (en) 1994-06-03
MX165116B (es) 1992-10-27
IE58141B1 (en) 1993-07-14
EP0182024A2 (en) 1986-05-28
FI875059L (fi) 1987-11-16
DK424685A (da) 1986-03-21
CZ283721B6 (cs) 1998-06-17
FI87564B (fi) 1992-10-15
NO874764D0 (no) 1987-11-16
HUT47576A (en) 1989-03-28
HU198934B (en) 1989-12-28

Similar Documents

Publication Publication Date Title
ES8703876A1 (es) Un procedimiento para la preparacion de derivados de purina.
ES8707514A1 (es) Procedimiento para preparar nuevos tetrahidro-benzotiazoles.
ES8503669A1 (es) Procedimiento para preparar derivados n-imidazolilicos de compuestos biciclicos.
ES8506021A1 (es) Procedimiento para preparar derivados de 4-oxo-1, 4-dihidroquinoleina
ES2089277T3 (es) Uso de material de nucleo especifico y capas para obtener formulaciones farmaceuticas estables a la decoloracion de compuestos labiles a los acidos.
ES8400415A1 (es) "un procedimiento para la preparacion de derivados de 2,4-diaminoquinazolina".
ES8800927A1 (es) Un procedimiento para preparar derivados de 1-aminobut-3-eno
ES8505972A1 (es) Un procedimiento para preparar derivados de pirimidina
ES8800132A1 (es) Un procedimiento para la produccion de compuestos de fenetanolamina
ES2066806T3 (es) Uso de la adenosina 5'-fosfato para el tratamiento de caquexia de cancer.
ES8302671A1 (es) "procedimiento de preparacion de nuevos derivados 3,4-dihidro-5h-2,3-benzodiazepinos y de sus sales de adicion acidas farmaceuticamente aceptables".
ES2059497T3 (es) Derivados del acido tiazolidin-4-carboxilico dotados de actividad farmacologica.
ES2075247T3 (es) Sales de amonio del acido n(5)-metil-5,6,7,8-tetrahidrofolico.
NO890567D0 (no) Anthracyklin-derivater.
ES8704965A1 (es) Un procedimiento para la preparacion de un antibiotico de macrolida
ES2062215T3 (es) Derivados aminoalcoxibencenicos sustituidos.
ES8606304A1 (es) Un procedimiento para preparar derivados de tiazina
ES8202015A1 (es) Un procedimiento para la preparacion de derivados de penici-lina
ES8703471A1 (es) Procedimiento para preparar nuevos derivados imidazo
ES8401042A1 (es) Un procedimiento para la preparacion de nuevos derivados de triazina.
ES8503677A1 (es) Procedimiento para la obtencion de azoles 2,4,5-trisustituidos. (como desglose y con prioridad de la patente espanola no.510.504, presentada el 17 de marzo de 1.982).
BG31505A3 (en) Composition containing alcohol
GB1073137A (en) Purine n-oxide derivatives
ES2065980T3 (es) Uso del acido 5-aminosalicilico en el tratamiento de alteraciones dermatologicas.
ES8701174A1 (es) Un metodo de preparacion de un compuesto de tiadiazina

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20061226